Treatment in inflammatory bowel disease affects IGRA performance
M. Arias, S. Riestra, R. DeFrancisco, A. Pando, J.J. Palacios, P. Escalante, J. Belda, L. Molinos, M. García-Clemente, B. Palomo, L. Rodrigo, A. Prieto, A. Losada, P. Casan (Oviedo, Rochester, Valencia, Spain)
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Session: Tuberculosis and immunologic assays
Session type: Poster Discussion
Number: 427
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arias, S. Riestra, R. DeFrancisco, A. Pando, J.J. Palacios, P. Escalante, J. Belda, L. Molinos, M. García-Clemente, B. Palomo, L. Rodrigo, A. Prieto, A. Losada, P. Casan (Oviedo, Rochester, Valencia, Spain). Treatment in inflammatory bowel disease affects IGRA performance. Eur Respir J 2012; 40: Suppl. 56, 427
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: